Search hospitals > Michigan > Monroe
Toledo Clinic Cancer Centers-Monroe
Claim this profileMonroe, Michigan 48162
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Non-Small Cell Lung Cancer
148 reported clinical trials
6 medical researchers
Summary
Toledo Clinic Cancer Centers-Monroe is a medical facility located in Monroe, Michigan. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Toledo Clinic Cancer Centers-Monroe is involved with conducting 148 clinical trials across 300 conditions. There are 6 research doctors associated with this hospital, such as REX MOWAT, MD, Abhijit B. Saste, Adam C. Walter, and Jeffrey H. Muler.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
REX MOWAT, MDToledo Clinic Cancer Centers-Toledo5 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
79 reported clinical trials
151 drugs studied
Abhijit B. SasteProMedica Flower Hospital5 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
12 reported clinical trials
28 drugs studied
Adam C. WalterProMedica Flower Hospital6 years of reported clinical research
Studies Cancer
Studies Adenocarcinoma
9 reported clinical trials
24 drugs studied
Jeffrey H. MulerProMedica Flower Hospital1 year of reported clinical research
Studies Cancer
Studies Bladder Cancer
10 reported clinical trials
27 drugs studied
Clinical Trials running at Toledo Clinic Cancer Centers-Monroe
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Pancreatic Cancer
Cancer
Pancreatic Carcinoma
Cutaneous Melanoma
Melanoma
Bladder Cancer
Multiple Myeloma
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Sacituzumab Govitecan
for Brain Metastases from Breast Cancer
This phase II trial studies the effect of sacituzumab govitecan in treating patients with HER2-negative breast cancer that has spread to the brain (brain metastases). Sacituzumab govitecan is a monoclonal antibody, called sacituzumab, linked to a chemotherapy drug, called govitecan. Sacituzumab is a form of targeted therapy because it attaches to specific molecules on the surface of cancer cells, known as Trop-2 receptors, and delivers govitecan to kill them. Giving sacituzumab govitecan may shrink the cancer in the brain and/or extend the time until the cancer gets worse.
Recruiting1 award Phase 212 criteria
Marker-Directed Monitoring
for Breast Cancer
This trial studies if using blood tests to decide when to do scans is as effective as the standard way for monitoring patients with a specific type of breast cancer that has spread. The blood tests act like an early warning system for cancer activity.
Recruiting1 award N/A
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Toledo Clinic Cancer Centers-Monroe?
Toledo Clinic Cancer Centers-Monroe is a medical facility located in Monroe, Michigan. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Toledo Clinic Cancer Centers-Monroe is involved with conducting 148 clinical trials across 300 conditions. There are 6 research doctors associated with this hospital, such as REX MOWAT, MD, Abhijit B. Saste, Adam C. Walter, and Jeffrey H. Muler.